Literature DB >> 35223185

A Gray Patient.

Gabriela Fortes Escobar1, Kelli Wagner Gomes2, Mariana Quirino Tubone3, Gabriela Maldonado4.   

Abstract

Entities:  

Year:  2022        PMID: 35223185      PMCID: PMC8824229          DOI: 10.5826/dpc.1201a41

Source DB:  PubMed          Journal:  Dermatol Pract Concept        ISSN: 2160-9381


× No keyword cloud information.

Case Presentation

A 46-year-old Caucasian woman presented with a 10-year history of an asymptomatic progressive darkening of the skin. There was no previous history of inflammation, and she denied the use of medications. Examination revealed symmetric blue-gray patches involving the face, trunk (Figure 1, A and B) and extremities. Dermoscopy showed a diffuse reticulated-homogenous brown-gray pigmentation (Figure 1C). Skin biopsy revealed multiple spindle-shaped dendritic melanocytes in the dermis (Figure 1D) and immunohistochemical staining was positive for Melan-A and HMB-45.
Figure 1

(A) and (B) Remarkable blue-gray pigmentation on the trunk. (C) Dermoscopy (10x) revealing a diffuse reticulated-homogenous brown-gray pigmentation. (D) Histopathology showing multiple spindle-shaped dendritic melanocytes in the dermis (arrows).

Teaching Point

Acquired dermal melanocytosis is a rare pigmentary disorder and its etiology remains unknown. Three theories may explain this disorder: migration of epidermal melanocytes to the dermis; migration of hair bulb melanocytes; or reactivation of pre-existing latent dermal melanocytes triggered by local inflammation or an unknown stimulus [1,2]. Melanin-containing dendritic melanocytes can be seen in the upper-middle portions of the dermis and, with the Tyndall effect, they result in a brown to bluish-gray skin pigmentation [2].
  2 in total

Review 1.  The spectrum of benign dermal dendritic melanocytic proliferations.

Authors:  C Baykal; Z Yılmaz; G P Sun; N Büyükbabani
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-03-14       Impact factor: 6.166

Review 2.  Clinically distinct form of acquired dermal melanocytosis with review of published work.

Authors:  Catherine Harrison-Balestra; Dijana Gugic; Vladimir Vincek
Journal:  J Dermatol       Date:  2007-03       Impact factor: 4.005

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.